Abstract

Simple SummaryCells undergoing stress, viral infection, and malignant transformation express natural killer group 2 member D (NKG2D) ligands on their surface, rendering them susceptible to immunosurveillance. Given this selective pressure exerted on viruses and cancer cells, many viruses and several cancers have evolved means of evading NKG2D recognition. This review highlights the various ways in which stresses, viruses and cancers induce the expression of NKG2D ligands, before comparing the similarities and differences between viral and cancer mechanisms to subsequently prevent recognition by the NKG2D system.The natural killer group 2 member D (NKG2D) receptor and its family of NKG2D ligands (NKG2DLs) are key components in the innate immune system, triggering NK, γδ and CD8+ T cell-mediated immune responses. While surface NKG2DL are rarely found on healthy cells, expression is significantly increased in response to various types of cellular stress, viral infection, and tumour cell transformation. In order to evade immune-mediated cytotoxicity, both pathogenic viruses and cancer cells have evolved various mechanisms of subverting immune defences and preventing NKG2DL expression. Comparisons of the mechanisms employed following virus infection or malignant transformation reveal a pattern of converging evolution at many of the key regulatory steps involved in NKG2DL expression and subsequent immune responses. Exploring ways to target these shared steps in virus- and cancer-mediated immune evasion may provide new mechanistic insights and therapeutic opportunities, for example, using oncolytic virotherapy to re-engage the innate immune system towards cancer cells.

Highlights

  • Cancer cells have long been defined with a set of characteristics, known as the ‘hallmarks of cancer’, with immune evasion rapidly emerging as a key player in cancer progression [1]

  • In contrast to T cell activation by clonotypic T cell receptor (TCR) interacting with specific peptides presented in the context of major histocompatibility complex (MHC), natural killer (NK) cells are inhibited by MHC molecules, and are instead activated

  • Vantourout et al describe a mechanism in which ultraviolet B (UVB) radiation upregulated MICA, MICB and ULBP2 in human epithelial cells via stress-induced epidermal growth factor receptor (EGFR) signalling, rather than due to the DNA damage response (DDR) [36]

Read more

Summary

Introduction

Cancer cells have long been defined with a set of characteristics, known as the ‘hallmarks of cancer’, with immune evasion rapidly emerging as a key player in cancer progression [1]. Viruses share several of these hallmarks with cancer cells to achieve a successful infection, as immune evasion is critically important for viruses

NKG2D Receptor and NK Cell Activation
NKG2D Ligands
Evading Detection by NKG2D
NKG2DL Expression in Healthy Cells and Autoimmunity
Cell Stress Induces NKG2DL mRNA and Protein Expression
Post-Transcriptional Regulation of NKG2DL Expression During Cell Stress
NKG2DL Expression Is Induced in Virally Infected Cells
Virus Immune Evasion
Viral Proteins Use a Range of Strategies to Downregulate NKG2DL Expression
Viral Strategies to Evade Pattern Recognition Receptors
Virus-Mediated Shedding of NKG2DL
Virus-Mediated Immune Subversion
NKG2DL Expression in Transformed Cells
Tumours Upregulate NKG2DLs via Chronic DDR
Cancer Strategies to Evade NKG2D
Loss of NKG2DLs May Be Involved in Metastatic Progression
Downregulation of NKG2Ds on Immune Cells by Cell-Bound and Soluble NKG2DLs
Mechanisms of NKG2DL Shedding by Tumour Cells
Soluble NKG2DLs Affect Other Immune Cell Types
Other Strategies Used by Tumours Subvert the NKG2D Immune Response
Viral and Cancer Immune Evasion Strategies Converge on the NKG2D Response
Conclusions and Outlook
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call